Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Triptorelin

Decapeptyl, Trelstar, Gonapeptyl, Pamorelin

Quick Stats
Studies 178
Trials 100
2023 pubmed 1 citations

Short-term clinical and hormonal effects of a deslorelin implant on late-prepubertal bitches - Based on flare-up signs.

Karadağ. M A MA; Schäfer-Somi. S S; Demir. M C MC; Kuru. M M; Aslan. S S; Kaya. D D

Key Findings

  • Only 6 of 16 late‑prepubertal bitches showed clinical proestrus after the implant
  • Serum progesterone and estradiol rose modestly at estrus onset (1.38 ng/ml and 37.38 pg/ml)
  • All dogs showed cytological changes, but the flare‑up response varied widely

Practical Outcomes

  • The findings don’t translate into actionable protocols for human longevity or performance. There’s no clear dosage or benefit for people, so biohackers can safely ignore this study.

Summary

The study tested a GnRH‑agonist implant (deslorelin) in young female dogs to see if it triggers early heat signs and hormone changes. Only some dogs showed heat signs, hormone levels rose only a little, and the response was highly variable, making it hard to predict. This research is about dog reproduction and doesn’t give useful guidance for human health or biohacking.

Abstract

Gonadotropin-releasing hormone (GnRH) agonists offer an alternative to surgical sterilization in prepubertal dogs, preserving ovarian and uterine functions. However, the clinical and hormonal effects of GnRH agonist application during the late-prepubertal stage remain insufficiently understood. This study aimed to investigate the clinical effect (flare-up) and hormonal changes, specifically serum progesterone (P4) and estradiol (E2) levels, in bitches treated with 4.7 mg deslorelin acetate (DA) implants (Suprelorin®, Virbac, F) during the late prepubertal period. Sixteen clinically healthy kangal cross-breed bitches, aged 7-8 months, with a mean body weight of 20.5 ± 0.8 kg, were implanted with DA. Estrus signs were monitored daily, and blood and vaginal cytological samples were collected every other day for four weeks. Cytological changes were analyzed for overall and superficial cell index. Six out of sixteen DA-treated bitches (EST group; n = 6) exhibited clinical proestrus 8.6 ± 0.6 days after implant insertion. The mean serum concentrations of P4 and E2 at the onset of estrus were 1.38 ± 0.32 ng/ml and 37.38 ± 10.07 pg/ml, respectively. Notably, all non-estrus (N-EST group; n = 10) bitches demonstrated an increase in superficial cell index, in addition to expected cytological changes observed in the EST group. On the 18th day post-implantation, the EST group exhibited a significantly higher number of superficial cells compared to the N-EST group (p < 0.001). DA implantation resulted in cytological profile alterations accompanied by a slight increase in estrogen concentrations in all dogs. However, the flare-up response exhibited significant variability, differing from that observed in adult dogs. This study highlights the importance of meticulous timing and breed-specific considerations when utilizing DA for puberty manipulation in late-prepubertal bitches. The observed cytological and hormonal changes in response to DA implants provide valuable insights, but the variability in flare-up responses warrants further investigation.

Study Information

Provider

pubmed

Year

2023

Date

2023-06-25T00:00:00.000Z

DOI

10.1016/j.theriogenology.2023.06.036

Citations

1

References

35